Skip to main content

Mural Oncology plc

MURADelisted Dec 5, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001971543

Mural Oncology plc was delisted on Dec 5, 2025; its insiders filed their last Form 4 on Dec 5, 2025; 61 institutions reported holding it in 13F filings for Q3 2025, worth $11.0M in total; no superinvestor held it.

Q3 2025 vs. Q2 2025

How the institutions holding Mural Oncology plc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of MURA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders6661−5
Shares8.23M5.32M−2.91M (−35.4%)
Value$20.3M$11.0M−$9.32M (−45.8%)

New holders (14)

Institutions that held Mural Oncology plc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to MURA in Q3 2025
InstitutionSharesValue% of portfolio
Omers Administration Corp511,000$1.06M0.01%
Deltec Asset Management LLC179,057$370.6K0.06%
Torno Capital, LLC170,000$351.9K0.05%
Yakira Capital Management, Inc.163,954$339.4K0.13%
PenderFund Capital Management Ltd.82,800$171.4K0.03%
BML Capital Management, LLC57,500$119.0K0.11%
Virtu Financial LLC55,721$115.0K0.01%
Shay Capital LLC45,088$93.3K0.02%
Jane Street Group, LLC40,609$84.1K0.00%
XTX Topco Ltd10,521$21.8K0.00%
CSS LLC10,500$21.7K0.00%
Two Sigma Advisers, LP10,200$21.1K0.00%
EverSource Wealth Advisors, LLC243$5030.00%
Principal Securities, Inc.10$210.00%

Sold out (19)

Institutions that held Mural Oncology plc at the end of Q2 2025 and filed for Q3 2025 without it.